Back

Evaluation of blood pressure lowering effect by generic and brand-name antihypertensive drug treatment: a prospective multicenter study in China

27 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Hypertension, risk factors and treatment Treatment ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Wei Li Zhang

National Center for Cardiovascular Diseases, Beijing (China)

9 More presentations in this session

Presentation thumbnail
Doctor I. Starodubtseva (Voronezh, RU)
Abstract Slides
Presentation thumbnail
Professor A. Mbakwem (Lagos, NG)
Abstract
Presentation thumbnail
Doctor H. Takase (Hamamatsu, JP)
Abstract
Presentation thumbnail
Professor K. Cho (Busan, KR)
Abstract
Presentation thumbnail
Doctor F. Abcha (Tunis, TN)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Hypertension, risk factors and treatment

The Event

Event poster

ESC Congress 2018

27 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in essential hypertension
27 August 2023
thumbnail
Congress Presentation
Is there an inter-manufacturer difference in generic clopidogrel response?
26 August 2022
thumbnail
Congress Presentation
Efficacy and safety of bisoprolol compared to other selective beta-1 blockers in the treatment of hypertension: a systematic review and meta-analysis of randomized parallel clinical trials
27 August 2021
thumbnail
Congress Presentation
Assesment of adherence to therapeutic recommendations among patients with hypertension
15 June 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources